Patient Experiences With Contraceptive Care Provided by Community Pharmacists Using the Pharmacist Resource to Implement Services as Modules Platform
PRISM-CS
Patient-Reported Outcomes of Contraceptive Services Rendered by Community Pharmacists Using the Pharmacist Resource to Implement Services as Modules Platform: The PRISM-CS Study
1 other identifier
interventional
75
1 country
5
Brief Summary
Hormonal contraceptives are medications that require a prescription, traditionally from a physician or advanced practice provider. Over the past decade, pharmacists have gained the authority to prescribe contraceptives in many states, allowing patients to access these medications directly in pharmacies without first seeing another healthcare provider. The Pharmacist Resource to Implement Services as Modules (PRISM) is an Electronic Health Record platform designed to streamline workflows and provide clinical decision support, making it easier and safer to deliver clinical services in community pharmacies. This pilot study will evaluate patient-reported outcomes for women receiving contraceptive services from pharmacists using the PRISM platform at five community pharmacies across the United States over a 12-week period. The study will assess the quality of care, contraception continuation and failure rates, side effect rates, preventative healthcare utilization, and overall patient experience with pharmacy contraceptive services.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2025
Shorter than P25 for not_applicable
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 5, 2025
CompletedFirst Posted
Study publicly available on registry
February 11, 2025
CompletedStudy Start
First participant enrolled
July 12, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2026
CompletedFebruary 4, 2026
February 1, 2026
4 months
February 5, 2025
February 2, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Person-Centered Contraceptive Counseling (PCCC) Measure
The percentage of patients who report that the pharmacist provided overall patient-centered care, as defined by achieving the highest rating on all four items of the PCCC survey.
Within 7 days post-intervention
Secondary Outcomes (1)
Three-month Contraceptive Continuation Rate
Within 97 days post-intervention
Other Outcomes (5)
Contraceptive Failure Rate
Within 97 days post-intervention
Contraceptive Side Effect Rate
Within 97 days post-intervention
Patient Contraceptive Satisfaction
Within 97 days post-intervention
- +2 more other outcomes
Study Arms (1)
Pharmacist-Rendered Contraceptive Services
EXPERIMENTALParticipants in this single-arm study are women seeking contraceptive services to prevent pregnancy in a community pharmacy setting. Pharmacists will deliver these services using an Electronic Health Record system that assists in evaluating each patient's eligibility based on the US Medical Eligibility Criteria (USMEC) guidelines. Pharmacists will be instructed to provide patient-centered contraceptive care. They retain full discretion to decide whether to issue a prescription, and if so, to select the most appropriate FDA-approved contraceptive option based on their clinical judgment.
Interventions
An electronic health record (EHR) platform specifically designed to support community pharmacists in delivering contraceptive services. The platform streamlines clinical workflows, provides clinical decision support, and promotes adherence to the US Medical Eligibility Criteria (USMEC) guidelines and state regulatory requirements.
Eligibility Criteria
You may qualify if:
- Women presenting for hormonal contraceptives
You may not qualify if:
- Age less than 18 years
- Pregnancy
- Unable to become pregnant
- Not English speaking
- Suspected coercion
- Unable to consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- OvaryIt, LLClead
- National Institutes of Health (NIH)collaborator
- University of Utahcollaborator
Study Sites (5)
Calabasas Pharmacy
Calabasas, California, 91302, United States
Desert Pharmacy
El Centro, California, 92243, United States
Local Health Pharmacy
Chicago, Illinois, 60647, United States
Wolves Den Pharmacy
Stanford, Montana, 59479, United States
Gaston Family Pharmacy
Gaston, South Carolina, 29053, United States
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 5, 2025
First Posted
February 11, 2025
Study Start
July 12, 2025
Primary Completion
November 1, 2025
Study Completion
January 31, 2026
Last Updated
February 4, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share